Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients
Condition(s):Central Nervous System DiseasesLast Updated:June 8, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Central Nervous System DiseasesLast Updated:June 8, 2015Completed
Condition(s):Central Nervous System DiseasesLast Updated:February 10, 2014Completed
Condition(s):Central Nervous System DiseasesLast Updated:February 10, 2023Completed
Condition(s):Central Nervous System Diseases; Multiple SclerosisLast Updated:November 9, 2021Completed
Condition(s):Central Nervous System Disease; Multiple SclerosisLast Updated:January 23, 2024Recruiting
Condition(s):Central Nervous System DiseasesLast Updated:September 2, 2022Terminated
Condition(s):Central Nervous System Diseases; Central Nervous System NeoplasmsLast Updated:July 18, 2018Completed
Condition(s):Central Nervous System DiseasesLast Updated:June 26, 2018Completed
Condition(s):Central Nervous System DiseasesLast Updated:January 11, 2021Unknown status
Condition(s):Central Nervous System DiseasesLast Updated:January 28, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.